EGFR Exon 19 Deletion Mutations and Systemic/Central Nervous System Miliary Metastasis: Clinical Correlations and Response to Therapy

被引:5
作者
Poonia, Seerat [1 ]
Berge, Eamon M. [2 ]
Aisner, Dara L. [3 ]
Damek, Denise [2 ]
Doebele, Robert C. [2 ]
机构
[1] Univ Colorado, Sch Med, Aurora, CO 80045 USA
[2] Univ Colorado, Dept Med, Sch Med, Div Med Oncol, Aurora, CO 80045 USA
[3] Univ Colorado, Dept Pathol, Sch Med, Aurora, CO 80045 USA
关键词
EGFR; Erlotinib; Leptomeningeal; Miliary nodules; Non-small-cell lung cancer; CELL LUNG-CANCER; LEPTOMENINGEAL METASTASES; ADENOCARCINOMA; ERLOTINIB; RECHALLENGE; GEFITINIB; BRAIN;
D O I
10.1016/j.cllc.2014.04.005
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:387 / 389
页数:3
相关论文
共 14 条
[1]   High dose weekly erlotinib achieves therapeutic concentrations in CSF and is effective in leptomeningeal metastases from epidermal growth factor receptor mutant lung cancer [J].
Clarke, Jennifer L. ;
Pao, William ;
Wu, Nian ;
Miller, Vincent A. ;
Lassman, Andrew B. .
JOURNAL OF NEURO-ONCOLOGY, 2010, 99 (02) :283-286
[2]   Carcinomatous Meningitis in Non-Small-Cell Lung Cancer: Response to High-Dose Erlotinib [J].
Dhruva, Nirav ;
Socinski, Mark A. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (22) :E31-E32
[3]   Functional Analysis of Epidermal Growth Factor Receptor (EGFR) Mutations and Potential Implications for EGFR Targeted Therapy [J].
Kancha, Rama Krishna ;
von Bubnoff, Nikolas ;
Peschel, Christian ;
Duyster, Justus .
CLINICAL CANCER RESEARCH, 2009, 15 (02) :460-467
[4]   Miliary Never-Smoking Adenocarcinoma of the Lung Strong Association with Epidermal Growth Factor Receptor Exon 19 Deletion [J].
Laack, Eckart ;
Simon, Ronald ;
Regier, Marc ;
Andritzky, Birte ;
Tennstedt, Pierre ;
Habermann, Christian ;
zur Verth, Christoph ;
Thoem, Ina ;
Grob, Tobias ;
Sauter, Guido ;
Bokemeyer, Carsten .
JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (01) :199-202
[5]   Gefitinib or Carboplatin-Paclitaxel in Pulmonary Adenocarcinoma. [J].
Mok, Tony S. ;
Wu, Yi-Long ;
Thongprasert, Sumitra ;
Yang, Chih-Hsin ;
Chu, Da-Tong ;
Saijo, Nagahiro ;
Sunpaweravong, Patrapim ;
Han, Baohui ;
Margono, Benjamin ;
Ichinose, Yukito ;
Nishiwaki, Yutaka ;
Ohe, Yuichiro ;
Yang, Jin-Ji ;
Chewaskulyong, Busyamas ;
Jiang, Haiyi ;
Duffield, Emma L. ;
Watkins, Claire L. ;
Armour, Alison A. ;
Fukuoka, Masahiro .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (10) :947-957
[6]   Successful EGFR-TKI Rechallenge of Leptomeningeal Carcinomatosis after Gefitinib-induced Interstitial Lung Disease [J].
Nakamichi, Shinji ;
Kubota, Kaoru ;
Horinouchi, Hidehito ;
Kanda, Shintaro ;
Fujiwara, Yutaka ;
Nokihara, Hiroshi ;
Yamamoto, Noboru ;
Tamura, Tomohide .
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2013, 43 (04) :422-425
[7]   Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial [J].
Rosell, Rafael ;
Carcereny, Enric ;
Gervais, Radj ;
Vergnenegre, Alain ;
Massuti, Bartomeu ;
Felip, Enriqueta ;
Palmero, Ramon ;
Garcia-Gomez, Ramon ;
Pallares, Cinta ;
Miguel Sanchez, Jose ;
Porta, Rut ;
Cobo, Manuel ;
Garrido, Pilar ;
Longo, Flavia ;
Moran, Teresa ;
Insa, Amelia ;
De Marinis, Filippo ;
Corre, Romain ;
Bover, Isabel ;
Illiano, Alfonso ;
Dansin, Eric ;
de Castro, Javier ;
Milella, Michele ;
Reguart, Noemi ;
Altavilla, Giuseppe ;
Jimenez, Ulpiano ;
Provencio, Mariano ;
Angel Moreno, Miguel ;
Terrasa, Josefa ;
Munoz-Langa, Jose ;
Valdivia, Javier ;
Isla, Dolores ;
Domine, Manuel ;
Molinier, Olivier ;
Mazieres, Julien ;
Baize, Nathalie ;
Garcia-Campelo, Rosario ;
Robinet, Gilles ;
Rodriguez-Abreu, Delvys ;
Lopez-Vivanco, Guillermo ;
Gebbia, Vittorio ;
Ferrera-Delgado, Lioba ;
Bombaron, Pierre ;
Bernabe, Reyes ;
Bearz, Alessandra ;
Artal, Angel ;
Cortesi, Enrico ;
Rolfo, Christian ;
Sanchez-Ronco, Maria ;
Drozdowskyj, Ana .
LANCET ONCOLOGY, 2012, 13 (03) :239-246
[8]   EGFR-Mutated Lung Cancer With T790M-Acquired Resistance in the Brain and Histologic Transformation in the Lung [J].
Scher, Kevin S. ;
Saldivar, Juan-Sebastian ;
Fishbein, Michael ;
Marchevsky, Alberto ;
Reckamp, Karen L. .
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2013, 11 (09) :1040-1044
[9]   Metastatic brain tumors from non-small cell lung cancer with EGFR mutations: Distinguishing influence of exon 19 deletion on radiographic features [J].
Sekine, Akimasa ;
Kato, Terufumi ;
Hagiwara, Eri ;
Shinohara, Takeshi ;
Komagata, Takanobu ;
Iwasawa, Tae ;
Satoh, Hiroaki ;
Tamura, Katsumi ;
Kasamatsu, Tomotaka ;
Hayashihara, Kenji ;
Saito, Takefumi ;
Takahashi, Hiroshi ;
Ogura, Takashi .
LUNG CANCER, 2012, 77 (01) :64-69
[10]   Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations [J].
Sequist, Lecia V. ;
Yang, James Chih-Hsin ;
Yamamoto, Nobuyuki ;
O'Byrne, Kenneth ;
Hirsh, Vera ;
Mok, Tony ;
Geater, Sarayut Lucien ;
Orlov, Sergey ;
Tsai, Chun-Ming ;
Boyer, Michael ;
Su, Wu-Chou ;
Bennouna, Jaafar ;
Kato, Terufumi ;
Gorbunova, Vera ;
Lee, Ki Hyeong ;
Shah, Riyaz ;
Massey, Dan ;
Zazulina, Victoria ;
Shahidi, Mehdi ;
Schuler, Martin .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (27) :3327-+